DALACINE 300 mg, hard capsule 16 capsules, CIP 3400934103650
Active ingredients: Clindamycin hydrochloride monohydrate, Clindamycin
Commercialized according to BDPMDispensing in France: Prescription only
Hard capsule16 capsules, CIP 3400934103650orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DALACINE 300 mg, gélule
- Pharmaceutical form
- gélule
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC-Aluminium de 16 gélule(s)
- Marketing authorisation holder
- PFIZER HOLDING FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Oct 1997
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64829519CIP73410365CIP133400934103650Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CLINDAMYCINE BASEgélule | 300 mg · une gélule | FT |
| CHLORHYDRATE DE CLINDAMYCINE HYDRATÉgélule | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.